Angiotensin II Type 1 Receptor Autoantibodies in Primary Aldosteronism

14Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Primary aldosteronism (PA) is the most common form of endocrine hypertension. Agonistic autoantibodies against the angiotensin II type 1 receptor (AT 1 R-Abs) have been described in transplantation medicine and women with pre-eclampsia and more recently in patients with PA. Any functional role of AT 1 R-Abs in either of the two main subtypes of PA (aldosterone-producing adenoma or bilateral adrenal hyperplasia) requires clarification. In this review, we discuss the studies performed to date on AT 1 R-Abs in PA.

Cite

CITATION STYLE

APA

Meyer, L. S., Gong, S., Reincke, M., Williams, T. A., & Williams, T. A. (2020, June 1). Angiotensin II Type 1 Receptor Autoantibodies in Primary Aldosteronism. Hormone and Metabolic Research. Georg Thieme Verlag. https://doi.org/10.1055/a-1120-8647

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free